Takashi Ishii

Dr. Takashi Ishii


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 January 2024 in Histochemistry and Cell Biology
Verified
Journal Article
Closed access
PDF file
SOShuhei Ogawa
Shuhei Ogawa
TITakashi Ishii
Takashi Ishii
TOTakahito Otani
Takahito Otani
YIYuko Inai
Yuko Inai
TMTakashi Matsuura
Takashi Matsuura
TITetsuichiro Inai
Tetsuichiro Inai

2 July 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
SMShohei Miyata
Shohei Miyata
TITakashi Ishii
Takashi Ishii
MOMisato Ogawa
Misato Ogawa
KIKan'ichiro Ishiuchi
Kan'ichiro Ishiuchi
SKSusumu Kitanaka
Susumu Kitanaka
The tumor suppressor gene p53 plays a central role in tumor suppression and is the most frequently mutated gene in human cancers; p53 mutation is most often associated with reduction or loss of function of the protein. BALL-1 and Panc-1 cells harbor p53 mutations and overexpress cyclin D1, making them resistant to drugs that induce p53-dependent apoptosis. 3EE, 20Ac-ingenol activates p53 in these cells via ATR/ATM activation, which induces the expression of p21 and PTEN, thereby inducing apoptosis in p53-mutant cancer cells. It is well known that the genetic basis of pancreatic pathway, which strongly induces p53-dependent apoptosis, is expected to be activated by the mutant Ras gene and genotoxic stress. It has also been reported that DNA damage responses induced by genotoxic stress triggers apoptosis specifically in pancreatic cancer cells expressing ARF in a p53-independent manner. In this study, we investigated whether the DNA damage response induced by 3EE, 20Ac-ingenol can restore the reduced or lost function of p53 in p53-mutant Panc-1 cells or induce a p53-independent apoptosis via ARF expression. Based on previous and current results, unlike in MCF-7 cells in which ARF expression was not detected, in p53-mutant Panc-1 cells, 3EE, 20Ac-ingenol induced the ARF-MDM2-p53 pathway via coactivation of the replication stress enhancement pathway induced by the excessive cyclin D1 expression and the activating Ras/β-catenin signaling pathway and thereby ARF, suggesting that 3EE, 20Ac-ingenol can restore the function of p53 in p53-mutant pancreatic cancer cells, and induces p53-independent apoptosis.